-

Latvia Insurance Industry Governance, Risk and Compliance (GRC) Analysis Report 2025: Key Requirements for the Establishment and Operation of Insurance and Reinsurance Companies and Intermediaries - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Latvia Insurance Industry - Governance, Risk and Compliance" report has been added to ResearchAndMarkets.com's offering.

The report provides detailed analysis of the insurance regulations for life, property, motor, liability, personal accident and health, and marine, aviation and transit insurance. The report specifies various requirements for the establishment and operation of insurance and reinsurance companies and intermediaries.

The report brings together the analyst's research, modeling and analysis expertise, giving insurers access to information on prevailing insurance regulations, and recent and upcoming changes in the regulatory framework, taxation and legal system in the country. The report also includes the scope of non-admitted insurance in the country.

The report provides insights into the governance, risk, and compliance framework pertaining to the insurance industry in Latvia, including:

  • An overview of the insurance regulatory framework in Latvia.
  • The latest key changes, and changes expected in the country's insurance regulatory framework.
  • Key regulations and market practices related to different types of insurance product in the country.
  • Rules and regulations pertaining to key classes of compulsory insurance, and the scope of non-admitted insurance in the country.
  • Key parameters including licensing requirements permitted foreign direct investment, minimum capital requirements, solvency and reserve requirements, and investment regulations.
  • Details of the tax and legal systems in the country.

Key Highlights

  • The Financial and Capital Market Commission regulates the Latvian insurance industry.
  • The new Solvency II standard became effective on January 1, 2016.
  • Non-admitted insurance is not allowed in the country. However, unlicensed insurers in EU and EEA Member
  • States are permitted to do non-admitted business.
  • Insurance premium tax (IPT) is not levied on insurance products.
  • 100% FDI is allowed in Latvia.

Scope

  • The report covers details of the insurance regulatory framework in Latvia.
  • The report contains details of the rules and regulations governing insurance products and insurance entities.
  • The report lists and analyzes key trends and developments pertaining to the country's insurance regulatory framework.
  • The report analyzes the rules and regulations pertaining to the establishment and operation of insurance businesses in the country.
  • The report provides details of taxation imposed on insurance products and insurance companies.

Reasons to Buy

  • Provides FAQ-style analytical insights comprising 129 knowledge elements on insurance compliance applicable to the country.
  • Gain insights into the insurance regulatory framework in Latvia.
  • Track the latest regulatory changes, and expected changes impacting the Latvian insurance industry.
  • Gain detailed information about the key regulations governing the establishment and operation of insurance entities in the country.
  • Understand key regulations and market practices pertaining to various types of insurance product.

Key Topics Covered:

1. Legislation Overview

1.1 Supervision and Control

1.2 Legislation

2. Compulsory Insurance

3. Non-Admitted Insurance Regulations

4. Company Registration and Operation

4.1 License

4.2 Foreign Direct Investment / Ownership

4.3 Minimum Capital Requirements

4.4 Solvency Margins

4.5 Reserve Requirements

4.6 Statutory Return Requirements

4.7 Fee Structure

5. Taxation

5.1 Tax on Insurance Premium

5.2 Corporate Income Tax

5.3 Corporate Capital Gains Tax

5.4 Value Added Tax

6. Legal System

7. Policy Practice

For more information about this report visit https://www.researchandmarkets.com/r/q7dlxg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The UAE automotive spare parts e-commerce market, valued at USD 1.2 billion, is experiencing a robust expansion influenced by the surge in online shopping, vehicle ownership, and the need for cost-effective solutions. The convenience provided by e-commerce platforms is r...

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...
Back to Newsroom